discharge by board certified neurologists. The clinical outcomes were defined as composite end points of restroke and mortality and were recorded with the mean follow-up period of 37.5 months. Results: There were 195 (13.1%) patients with AF. The patients with AF had significantly higher median CHADS2 and CHA2DS2-VASc scores than the patients without AF (p<0.001). Patients with higher CHADS2 and CHA2DS2-VASc scores had significantly higher total infarction volume, arterial stenosis score, NIHSS scores at discharge and poorer clinical outcomes. After adjusting age, gender and AF, only CHA2DS2-VASc scores could predict both restroke and composite end points. Conclusion: Pre-stroke CHA2DS2-VASc scores appear to have better clinical value for predicting the severity of infarction and long-term clinical outcomes in acute ischemic stroke patients with and without AF. Acknowledgement/Funding: Chung Shan Medical University Hospital (CSH-2013-A-012) and National Science Council (NSC) (NSC-101-2314-B-040-017-MY2), Taiwan, R.O.C. Background: Contrast-induced nephropathy (CIN), occurs in 7-20% in patients undergoing cardiac catheterization and has been associated with increased morbidity, mortality and cost. CIN prevention strategies can reduce the percentage of affected patients at the cost of reduced efficiency. Successful selection of outcome and resource-effective prevention strategies will ultimately rely on the operator's ability to identify patients at increased risk for CIN. Purpose: To compare the operator's subjective CIN risk assessment against the objective risk assessment obtained using an evidence-based risk model. Methods: A validated risk model (Mehran et al., JACC, 2004) for CIN estimation was used. Using clinical and operation-specific factors, the model groups patients in four risk bins: 7.5%, 14%, 26.1% and 57.3% likelihood of developing CIN. Following cardiac catheterization, operators reported the patient's risk factors included in the risk model and his/her subjective estimate of CIN on a paper sheet. The objective risk percentage was based off reported risk factors and compared against operator subjective assessment. Major (minor) discrepancies were tallied, defined as the objective risk model assessment exceeding the subjective assessment by ≥20% (≥10% and <20%) . The average subjective and objective risk assessments were computed and tested for significance on the entire study sample (paired t-test, <0.05) and within the risk bins (t-test, <0.05) Results: 50 patients were included in the study, mean age 64, 40% female, 36% diabetes, mean serum creatinine 1.4 mg/dL. Major discrepancies were found in 18% of patients and minor discrepancies in 18%. Average subjective risk was lower than objective risk (p=0.001): 13% ± 13% versus 20% ± 16%. Average subjective risk estimate was 8% ± 6% in bin 7.5%; 10% ± 8% in bin 14%; 14% ± 8% in bin 26.1%; 28% ± 31% in bin 57.3%. Differences were only significant for bin 26.1% (P<0.001). The sample size may have been too small for the other bins. Of all patients, 38 had follow-up data to calculate the actual incidence of CIN. There were 5 patients that developed CIN, 2 of whom had minor discrepancies and 1 had a major discrepancy.
Background: Contrast-induced nephropathy (CIN), occurs in 7-20% in patients undergoing cardiac catheterization and has been associated with increased morbidity, mortality and cost. CIN prevention strategies can reduce the percentage of affected patients at the cost of reduced efficiency. Successful selection of outcome and resource-effective prevention strategies will ultimately rely on the operator's ability to identify patients at increased risk for CIN. Purpose: To compare the operator's subjective CIN risk assessment against the objective risk assessment obtained using an evidence-based risk model. Methods: A validated risk model (Mehran et al., JACC, 2004) for CIN estimation was used. Using clinical and operation-specific factors, the model groups patients in four risk bins: 7.5%, 14%, 26.1% and 57.3% likelihood of developing CIN. Following cardiac catheterization, operators reported the patient's risk factors included in the risk model and his/her subjective estimate of CIN on a paper sheet. The objective risk percentage was based off reported risk factors and compared against operator subjective assessment. Major (minor) discrepancies were tallied, defined as the objective risk model assessment exceeding the subjective assessment by ≥20% (≥10% and <20%) . The average subjective and objective risk assessments were computed and tested for significance on the entire study sample (paired t-test, <0.05) and within the risk bins (t-test, <0.05) Results: 50 patients were included in the study, mean age 64, 40% female, 36% diabetes, mean serum creatinine 1.4 mg/dL. Major discrepancies were found in 18% of patients and minor discrepancies in 18%. Average subjective risk was lower than objective risk (p=0.001): 13% ± 13% versus 20% ± 16%. Average subjective risk estimate was 8% ± 6% in bin 7.5%; 10% ± 8% in bin 14%; 14% ± 8% in bin 26.1%; 28% ± 31% in bin 57.3%. Differences were only significant for bin 26.1% (P<0.001). The sample size may have been too small for the other bins. Of all patients, 38 had follow-up data to calculate the actual incidence of CIN. There were 5 patients that developed CIN, 2 of whom had minor discrepancies and 1 had a major discrepancy.
Conclusion:
Discrepancies between the operator's subjective CIN risk assessment and that of the objective risk model were found in a substantial portion of cases. The subjective risk assessment was significantly lower than the modelbased risk prediction. Operator's discordance with an evidence-based risk model may limit their ability to adopt the appropriate CIN mitigation strategy.
